Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

James D. Chambers, Rachel Lai, Nikoletta M. Margaretos, Ari D. Panzer, Joshua T. Cohen, Peter J. Neumann

JAMA · 2020 · 33 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

This study uses US commercial health plan insurance data to characterize coverage for biosimilar drugs compared with reference products.

References

2